# A novel paradigm for chronic subdural hematoma: regenerative medicine strategies targeting the pathological microenvironment

## TL;DR

This paper explores new regenerative strategies to treat chronic subdural hematoma by targeting its complex microenvironment.

## Contribution

The paper introduces regenerative medicine approaches to treat chronic subdural hematoma by focusing on its pathological microenvironment.

## Key findings

- Chronic subdural hematoma involves chronic inflammation, abnormal angiogenesis, and ECM imbalance.
- Regenerative strategies like immunomodulation and stem cell therapy target the microenvironment for treatment.
- These approaches aim to restore tissue homeostasis and shift treatment from surgery to biological remodeling.

## Abstract

This review systematically summarizes the pathological microenvironment characteristics of chronic subdural hematoma (CSDH) and the regenerative medicine strategies for its intervention. CSDH is no longer regarded as a simple mechanical hematoma but is recognized as a dynamic pathological process driven by chronic inflammation, abnormal angiogenesis, extracellular matrix (ECM) imbalance, and interactions among immune cells. The article focuses on key cellular and molecular mechanisms within the microenvironment and highlights regulatory strategies targeting inflammation, vascular leakage, and matrix remodeling. These strategies include immunomodulation, stem cell therapy, exosome- and nanomaterial-based delivery systems. Such innovative approaches aim to restore tissue homeostasis at the biological level, advancing CSDH treatment from traditional surgical drainage toward microenvironment remodeling and functional reconstruction. They provide a theoretical basis for achieving precise and regenerative clinical therapies.